Evaluation and Management of Status Epilepticus
Publication Date: April 24, 2012
Last Updated: March 14, 2022
Recommendations
SE Definition and Classification
SE should be defined as 5 min or more of continuous clinical and/or electrographic seizure activity or recurrent seizure activity without recovery between seizures. (Moderate, Strong)
317067
SE should be classified as either convulsive SE (convulsions that are associated with rhythmic jerking of the extremities) or non-convulsive SE (seizure activity seen on EEG without the clinical findings associated with convulsive SE). (High, Strong)
317067
Refractory SE should be defined as SE that does not respond to the standard treatment regimens, such as an initial benzodiazepine followed by another AED. (Moderate, Strong)
317067
The etiology of SE should be diagnosed and treated as soon as possible. (High, Strong)
317067
Treatment
The treatment of convulsive SE should occur rapidly and continue sequentially until clinical seizures are halted. (High, Strong)
317067
The treatment of SE should occur rapidly and continue sequentially until electrographic seizures are halted. (Moderate, Strong)
317067
Critical care treatment and monitoring should be started simultaneously with emergent initial therapy and continued until further therapy is consider successful or futile. (Moderate, Strong)
317067
Treatment options
Benzodiazepines should be given as emergent initial therapy. (High, Strong)
317067
Lorazepam is the drug of choice for IV administration. (Moderate, Strong)
317067
Midazolam is the drug of choice for IM administration. (Moderate, Strong)
317067
Rectal diazepam can be given when there is no IV access and IM administration of midazolam is contraindicated. (Moderate, Strong)
317067
Urgent control AED therapy recommendations include use of IV fosphenytoin/phenytoin, valproate sodium, or levetiracetam. (Moderate, Strong)
317067
Refractory SE therapy recommendations should consist of continuous infusion AEDs, but vary by the patient’s underlying condition. (Low, Strong)
317067
Dosing of continuous infusion AEDs for RSE should be titrated to cessation of electrographic seizures or burst suppression. (Very Low, Strong)
317067
A period of 24–48 h of electrographic control is recommended prior to slow withdrawal of continuous infusion AEDs for RSE. (Very Low, Weak)
317067
During the transition from continuous infusion AEDs in RSE, it is suggested to use maintenance AEDs and monitor for recurrent seizures by cEEG during the titration period. If the patient is being treated for RSE at a facility without cEEG capabilities, consider transfer to a facility that can offer cEEG monitoring. (Very Low, Strong)
317067
Alternative therapies can be considered if cessation of seizures cannot be achieved; however, it is recommended to reserve these therapies for patients who do not respond to RSE AED treatment and consider transfer of the patient if they are not being managed by an ICU team that specialize in the treatment of SE and/or cannot provide cEEG monitoring. (Very Low, Weak)
317067
cEEG
The use of cEEG is usually required for the treatment of SE. (Very Low, Strong)
317067
Continuous EEG monitoring should be initiated within 1 h of SE onset if ongoing seizures are suspected. (Low, Strong)
317067
The duration of cEEG monitoring should be at least 48 h in comatose patients to evaluate for non-convulsive seizures. (Low, Strong)
317067
The person reading EEG in the ICU setting should have specialized training in cEEG interpretation, including the ability to analyze raw EEG as well as quantitative EEG tracings. (Low, Strong)
317067
Recommendation Grading
Overview
Title
Evaluation and Management of Status Epilepticus
Authoring Organization
Neurocritical Care Society
Publication Month/Year
April 24, 2012
Last Updated Month/Year
January 8, 2024
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Inclusion Criteria
Female, Male, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Emergency care
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Assessment and screening, Diagnosis, Management, Treatment
Diseases/Conditions (MeSH)
D013226 - Status Epilepticus
Keywords
status epilecticus